Drug Delivery Devices - Europe

Europe

Highlights

In Europe, revenue in the Drug Delivery Devices market market is projected to reach US$8.54bn in 2024.
The revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 5.05%, leading to a market volume of US$10.92bn by 2029.
When compared globally, the majority of revenue is expected to be generated the United States, with a projection of US$15.01bn in 2024.
The European market for drug delivery devices is increasingly focusing on advanced technologies, enhancing patient compliance and personalized medicine across various healthcare sectors.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market within the Medical Devices sector in Europe is witnessing mild growth, influenced by factors such as technological advancements, increasing demand for personalized medicine, and the rising prevalence of chronic diseases among the population.

Customer preferences: Consumers in Europe are showing a growing preference for user-friendly drug delivery devices that offer convenience and enhanced self-management capabilities. The rise in telehealth has led to increased interest in devices that integrate with digital platforms for real-time medication tracking. Additionally, an aging population is driving demand for more sophisticated drug delivery systems tailored to specific health needs. Cultural shifts towards preventive healthcare are also prompting users to prioritize devices that enable proactive management of chronic conditions, reflecting a broader trend toward personalized health solutions.

Trends in the market: In Europe, the Drug Delivery Devices market is experiencing a surge in demand for user-friendly devices that enhance self-management and convenience. The integration of telehealth services is fostering interest in devices that facilitate real-time medication tracking through digital platforms. Additionally, the aging population is propelling the need for advanced drug delivery systems tailored to specific health requirements. As cultural attitudes shift towards preventive healthcare, there is an increasing focus on personalized health solutions, prompting manufacturers to innovate and adapt their offerings to meet these evolving consumer preferences.

Local special circumstances: In Europe, the Drug Delivery Devices market is shaped by diverse healthcare regulations that vary by country, influencing product approval processes and safety standards. Cultural attitudes towards healthcare emphasize patient autonomy and preventive measures, encouraging the adoption of innovative drug delivery systems that support self-management. Additionally, geographical disparities in healthcare access drive demand for devices that integrate seamlessly with telehealth services, enabling remote monitoring and personalized treatment plans tailored to the needs of an aging population.

Underlying macroeconomic factors: The Drug Delivery Devices market in Europe is significantly influenced by macroeconomic factors such as national economic stability, healthcare spending, and demographic trends. Countries with robust economies and increased public investment in healthcare are fostering innovation in drug delivery technologies, enhancing market growth. Additionally, the rising prevalence of chronic diseases and an aging population necessitate more efficient delivery systems, driving demand. Fiscal policies aimed at improving healthcare access and affordability further support the adoption of advanced devices, while global economic trends, including supply chain dynamics and trade regulations, also play a crucial role in shaping market performance.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.